Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

Bullboard Posts
Comment by PoorOpinionon May 28, 2018 2:04pm
128 Views
Post# 28089586

RE:Important week

RE:Important weekI've got a question for the people here.

This board is confident about good data from the conference, so am I there are a number of strong indicators for this. Do you think the market is also already confident of good data as well and so these results are already priced in now? What will it take to see a good pop from the data? Personnally I'm unsure what to expect, there is potential for some really strong data from the 300mg dosing given that the recent abstract moved the 100mg dosing story forward somewhat. If the 300mg dose is just more of what we already have does the SP stay the same? If the 300mg dosing data is a significant step up from the 100mg dose does this move the stock?


I think there are plenty of other sources of good news for this stock in the near future as well, I'm not trying to sow doubt, just curious to see what people are expecting from this particular data release. I'm never quite confident the extent to which data move biotech stock, one always imagines greatly because this is one of the obvious sources of value in this sector but sometimes it doesn't move stock or the moves are transient, its a mystery to me sometimes.
Bullboard Posts